Fred Alger Management, LLC Pmv Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $340,291 - $826,949	-36,868 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $663,142 - $1.05 Million	-44,626 Reduced 54.76%	36,868 $768,000
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $873,902 - $1.32 Million	-43,717 Reduced 34.91%	81,494 $1.88 Million
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $3.36 Million - $4.58 Million	125,211 New	125,211 $3.73 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $68.4M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.